{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:30:53Z","timestamp":1795026653819,"version":"4.10.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Insulin resistance is associated with the occurrence of stroke and atherosclerotic disease. However, the relationship between insulin resistance and the prognosis of acute ischemic stroke in non-diabetic patients is unclear. We hypothesized that insulin resistance might affect short-term functional recovery after acute ischemic stroke in non-diabetic patients. Between May 2014 and December 2016, 1377 consecutive patients with acute ischemic stroke were enrolled from a prospectively maintained stroke registry. After excluding patients with transient ischemic attacks (TIA), pre-stroke disabilities, diabetes mellitus, and patients with incomplete evaluations, 517 patients were included in the study. The homeostasis model assessment of insulin resistance (HOMA-IR) score was used to evaluate the degree of insulin resistance. The patients with the highest quartile of log HOMA-IR index scores were younger and had higher fasting blood glucose, total cholesterol, triglycerides, low-density lipoprotein, and HbA1c levels. Multivariable logistic regression analysis revealed that log HOMA-IR scores were independently associated with poor prognosis after adjusting for age and sex and p\u2009&lt;\u20090.1 in univariable analysis. Insulin resistance was associated with the poor functional outcome of non-diabetic stroke patients. This evidence supports treating insulin resistance in acute ischemic stroke patients with blood glucose levels within the normal range.<\/jats:p>","DOI":"10.1038\/s41598-020-80315-z","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:15:21Z","timestamp":1610536521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Yoonkyung","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo\u2010Keun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungmi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"80315_CR1","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1210\/jcem.86.9.7713","volume":"86","author":"SE Kahn","year":"2001","unstructured":"Kahn, S. E. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J. Clin. Endocrinol. Metab. 86, 4047\u20134058. https:\/\/doi.org\/10.1210\/jcem.86.9.7713 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"80315_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1043-2760(00)00323-4","volume":"11","author":"RN Bergman","year":"2000","unstructured":"Bergman, R. N. & Ader, M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11, 351\u2013356 (2000).","journal-title":"Trends Endocrinol. Metab."},{"key":"80315_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"80315_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1515\/revneuro-2013-0034","volume":"24","author":"C Gao","year":"2013","unstructured":"Gao, C., Liu, Y., Li, L. & H\u00f6lscher, C. New animal models of Alzheimer\u2019s disease that display insulin desensitization in the brain. Rev. Neurosci. 24, 607\u2013615. https:\/\/doi.org\/10.1515\/revneuro-2013-0034 (2013).","journal-title":"Rev. Neurosci."},{"key":"80315_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.12688\/f1000research.8300.2","volume":"5","author":"LE Stoeckel","year":"2016","unstructured":"Stoeckel, L. E. et al. Complex mechanisms linking neurocognitive dysfunction\u00a0to insulin resistance and other metabolic dysfunction. F1000Research 5, 353. https:\/\/doi.org\/10.12688\/f1000research.8300.2 (2016).","journal-title":"F1000Research"},{"key":"80315_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5483\/bmbrep.2009.42.8.475","volume":"42","author":"SM de la Monte","year":"2009","unstructured":"de la Monte, S. M. Insulin resistance and Alzheimer\u2019s disease. BMB Rep. 42, 475\u2013481. https:\/\/doi.org\/10.5483\/bmbrep.2009.42.8.475 (2009).","journal-title":"BMB Rep."},{"key":"80315_CR7","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s41598-020-58332-9","volume":"10","author":"MM Teixeira","year":"2020","unstructured":"Teixeira, M. M. et al. Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Sci. Rep. 10, 1596. https:\/\/doi.org\/10.1038\/s41598-020-58332-9 (2020).","journal-title":"Sci. Rep."},{"key":"80315_CR8","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/wnl.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott, A. et al. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 1937\u20131942. https:\/\/doi.org\/10.1212\/wnl.53.9.1937 (1999).","journal-title":"Neurology"},{"key":"80315_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C. & Scheltens, P. Risk of dementia in diabetes mellitus: A systematic review. Lancet. Neurol. 5, 64\u201374. https:\/\/doi.org\/10.1016\/s1474-4422(05)70284-2 (2006).","journal-title":"Lancet. Neurol."},{"key":"80315_CR10","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Br\u00fcning","year":"2000","unstructured":"Br\u00fcning, J. C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122\u20132125. https:\/\/doi.org\/10.1126\/science.289.5487.2122 (2000).","journal-title":"Science"},{"key":"80315_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1172\/jci22217","volume":"114","author":"X Lin","year":"2004","unstructured":"Lin, X. et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J. Clin. Investig. 114, 908\u2013916. https:\/\/doi.org\/10.1172\/jci22217 (2004).","journal-title":"J. Clin. Investig."},{"key":"80315_CR12","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.2337\/db15-0596","volume":"64","author":"CA Grillo","year":"2015","unstructured":"Grillo, C. A. et al. Hippocampal insulin resistance impairs spatial learning and synaptic plasticity. Diabetes 64, 3927\u20133936. https:\/\/doi.org\/10.2337\/db15-0596 (2015).","journal-title":"Diabetes"},{"key":"80315_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.Str.0000115297.92132.84","volume":"35","author":"PJ Lindsberg","year":"2004","unstructured":"Lindsberg, P. J. & Roine, R. O. Hyperglycemia in acute stroke. Stroke 35, 363\u2013364. https:\/\/doi.org\/10.1161\/01.Str.0000115297.92132.84 (2004).","journal-title":"Stroke"},{"key":"80315_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40618-016-0584-8","volume":"40","author":"C Savopoulos","year":"2017","unstructured":"Savopoulos, C. et al. Is management of hyperglycaemia in acute phase stroke still a dilemma?. J. Endocrinol. Investig. 40, 457\u2013462. https:\/\/doi.org\/10.1007\/s40618-016-0584-8 (2017).","journal-title":"J. Endocrinol. Investig."},{"key":"80315_CR15","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/str.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers, W. J. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50, e344\u2013e418. https:\/\/doi.org\/10.1161\/str.0000000000000211 (2019).","journal-title":"Stroke"},{"key":"80315_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12975-016-0453-y","volume":"7","author":"DF Bas","year":"2016","unstructured":"Bas, D. F., Ozdemir, A. O., Colak, E. & Kebapci, N. Higher insulin resistance level is associated with worse clinical response in acute ischemic stroke patients treated with intravenous thrombolysis. Transl. Stroke Res. 7, 167\u2013171. https:\/\/doi.org\/10.1007\/s12975-016-0453-y (2016).","journal-title":"Transl. Stroke Res."},{"key":"80315_CR17","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.2337\/dc11-1242","volume":"34","author":"AI Calleja","year":"2011","unstructured":"Calleja, A. I. et al. Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke. Diabetes Care 34, 2413\u20132417. https:\/\/doi.org\/10.2337\/dc11-1242 (2011).","journal-title":"Diabetes Care"},{"key":"80315_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1161\/01.str.0000071108.00234.0e","volume":"34","author":"WN Kernan","year":"2003","unstructured":"Kernan, W. N. et al. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke. Stroke 34, 1431\u20131436. https:\/\/doi.org\/10.1161\/01.str.0000071108.00234.0e (2003).","journal-title":"Stroke"},{"key":"80315_CR19","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","volume":"374","author":"WN Kernan","year":"2016","unstructured":"Kernan, W. N. et al. Pioglitazone after ischemic stroke or transient ischemic attack. N. Engl. J. Med. 374, 1321\u20131331. https:\/\/doi.org\/10.1056\/NEJMoa1506930 (2016).","journal-title":"N. Engl. J. Med."},{"key":"80315_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","volume":"333","author":"P Sa-Nguanmoo","year":"2017","unstructured":"Sa-Nguanmoo, P. et al. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Toxicol. Appl. Pharmacol. 333, 43\u201350. https:\/\/doi.org\/10.1016\/j.taap.2017.08.005 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"80315_CR21","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2337\/db07-1472","volume":"57","author":"S Han","year":"2008","unstructured":"Han, S. et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes 57, 1723\u20131729. https:\/\/doi.org\/10.2337\/db07-1472 (2008).","journal-title":"Diabetes"},{"key":"80315_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0140-6736(18)32590-x","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker, T. A. et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials. Lancet 393, 31\u201339. https:\/\/doi.org\/10.1016\/s0140-6736(18)32590-x (2019).","journal-title":"Lancet"},{"key":"80315_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/strokeaha.116.015613","volume":"48","author":"J Jing","year":"2017","unstructured":"Jing, J. et al. Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: The ACROSS-China Study (abnormal glucose regulation in patients with acute stroke across China). Stroke 48, 887\u2013893. https:\/\/doi.org\/10.1161\/strokeaha.116.015613 (2017).","journal-title":"Stroke"},{"key":"80315_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams, H. P. Jr. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24, 35\u201341 (1993).","journal-title":"Stroke"},{"key":"80315_CR25","doi-asserted-by":"publisher","first-page":"e1470","DOI":"10.1212\/wnl.0000000000005358","volume":"90","author":"T Ago","year":"2018","unstructured":"Ago, T. et al. Insulin resistance and clinical outcomes after acute ischemic stroke. Neurology 90, e1470\u2013e1477. https:\/\/doi.org\/10.1212\/wnl.0000000000005358 (2018).","journal-title":"Neurology"},{"key":"80315_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/0006-8993(90)91361-J","volume":"533","author":"F Yamaguchi","year":"1990","unstructured":"Yamaguchi, F. et al. Insulin-like growth factor I (IGF-I) distribution in the tissue and extracellular compartment in different regions of rat brain. Brain Res. 533, 344\u2013347 (1990).","journal-title":"Brain Res."},{"key":"80315_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.ph.49.030187.002003","volume":"49","author":"DG Baskin","year":"1987","unstructured":"Baskin, D. G., Figlewicz, D. P., Woods, S. C., Porte, D. Jr. & Dorsa, D. M. Insulin in the brain. Annu. Rev. Physiol. 49, 335\u2013347. https:\/\/doi.org\/10.1146\/annurev.ph.49.030187.002003 (1987).","journal-title":"Annu. Rev. Physiol."},{"key":"80315_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/B978-0-12-027310-2.50017-7","volume":"10","author":"D Le Roith","year":"1983","unstructured":"Le Roith, D. et al. Insulin in brain and other extrapancreatic tissues of vertebrates and nonvertebrates. Adv. Metab. Disord. 10, 303\u2013340 (1983).","journal-title":"Adv. Metab. Disord."},{"key":"80315_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s001250051457","volume":"43","author":"JR Zierath","year":"2000","unstructured":"Zierath, J. R., Krook, A. & Wallberg-Henriksson, H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43, 821\u2013835. https:\/\/doi.org\/10.1007\/s001250051457 (2000).","journal-title":"Diabetologia"},{"key":"80315_CR30","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/joe-16-0598","volume":"233","author":"S Di Meo","year":"2017","unstructured":"Di Meo, S., Iossa, S. & Venditti, P. Skeletal muscle insulin resistance: Role of mitochondria and other ROS sources. J. Endocrinol. 233, R15\u2013R42. https:\/\/doi.org\/10.1530\/joe-16-0598 (2017).","journal-title":"J. Endocrinol."},{"key":"80315_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/1479164115604120","volume":"13","author":"K Prakash","year":"2016","unstructured":"Prakash, K., Chandran, D. S., Khadgawat, R., Jaryal, A. K. & Deepak, K. K. Correlations between endothelial function in the systemic and cerebral circulation and insulin resistance in type 2 diabetes mellitus. Diabetes Vasc. Dis. Res. 13, 49\u201355. https:\/\/doi.org\/10.1177\/1479164115604120 (2016).","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"80315_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/MCO.0b013e32819f8ecd","volume":"10","author":"R Muniyappa","year":"2007","unstructured":"Muniyappa, R. & Quon, M. J. Insulin action and insulin resistance in vascular endothelium. Curr. Opin. Clin. Nutr. Metab. Care 10, 523\u2013530. https:\/\/doi.org\/10.1097\/MCO.0b013e32819f8ecd (2007).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"80315_CR33","doi-asserted-by":"publisher","first-page":"21j","DOI":"10.1016\/S0002-9149(99)00353-7","volume":"84","author":"WA Hsueh","year":"1999","unstructured":"Hsueh, W. A. & Law, R. E. Insulin signaling in the arterial wall. Am. J. Cardiol. 84, 21j\u201324j (1999).","journal-title":"Am. J. Cardiol."},{"key":"80315_CR34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1161\/strokeaha.107.502799","volume":"39","author":"H Sourij","year":"2008","unstructured":"Sourij, H. et al. Insulin resistance as a risk factor for carotid atherosclerosis: A comparison of the Homeostasis Model Assessment and the short insulin tolerance test. Stroke 39, 1349\u20131351. https:\/\/doi.org\/10.1161\/strokeaha.107.502799 (2008).","journal-title":"Stroke"},{"key":"80315_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2013.06.017","volume":"230","author":"MC Gage","year":"2013","unstructured":"Gage, M. C. et al. Endothelium-specific insulin resistance leads to accelerated atherosclerosis in areas with disturbed flow patterns: A role for reactive oxygen species. Atherosclerosis 230, 131\u2013139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.06.017 (2013).","journal-title":"Atherosclerosis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80315-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80315-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80315-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:11:58Z","timestamp":1670033518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80315-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80315"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80315-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1229"}}